Company intelligence / Profile preview
Creative BioTherapeutics
Gurnee, Illinois, United Statescreativebio.tech ↗
- Ownership
- Private
- Employees
- ~10
- Development stage
- Other
01
Overview
Creative BioTherapeutics (CBT) is an emerging biotechnology company focused on developing novel biologics for treatment-resistant cancers and viral infections. The company's research centers on the role of extracellular Glucose-Regulated Protein 78 (ecGRP78) in the tumor microenvironment, which contributes to drug resistance and immune evasion. Its lead candidate, CBT300, is a first-in-class biologic designed to inhibit this survival pathway, thereby reversing resistance and enabling immune system activation. CBT is also exploring the application of its technology in viral diseases, including COVID-19 and Ebola, through collaborations with organizations like the US Army.
- Therapeutic areas
- Infectious DiseasesOncology
- Modalities
- BiologicRecombinant protein
- Industry
- Biotech
02
Drug pipeline
1 asset03
Partnerships
US Army research division
Beyond the preview
Go deeper on Creative BioTherapeutics.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Creative BioTherapeutics.